Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |